In Vitro Expression of N‐Acetyl Aspartate by Oligodendrocytes
暂无分享,去创建一个
[1] D. Gadian,et al. Proton Nuclear Magnetic Resonance Spectroscopy of Primary Cells Derived from Nervous Tissue , 1996, Journal of neurochemistry.
[2] F. Yatsu,et al. ACETATE METABOLISM IN THE NERVOUS SYSTEM. N‐ACETYL‐l‐ASPARTIC ACID AND THE BIOSYNTHESIS OF BRAIN LIPIDS * , 1966, Journal of neurochemistry.
[3] D. Silberberg,et al. Galactocerebroside is a specific cell-surface antigenic marker for oligodendrocytes in culture , 1978, Nature.
[4] R. Harris,et al. Brain sulfatide and non-lipid sulfate metabolism in hypothyroid rats. , 1979, Research communications in chemical pathology and pharmacology.
[5] S. Williams,et al. Cell type-specific fingerprinting of meningioma and meningeal cells by proton nuclear magnetic resonance spectroscopy. , 1995, Cancer research.
[6] M Noble,et al. Specific Expression of N‐Acetylaspartate in Neurons, Oligodendrocyte‐Type‐2 Astrocyte Progenitors, and Immature Oligodendrocytes In Vitro , 1992, Journal of neurochemistry.
[7] D. Gadian,et al. Localized 1H NMR spectroscopy in Canavan's Disease: A report of two cases , 1991, Magnetic resonance in medicine.
[8] N. Jagannathan,et al. Reversal of abnormalities of myelination by thyroxine therapy in congenital hypothyroidism: localized in vivo proton magnetic resonance spectroscopy (MRS) study. , 1998, Brain research. Developmental brain research.
[9] J S Wolinsky,et al. Serial proton magnetic resonance spectroscopic imaging, contrast‐enhanced magnetic resonance imaging, and quantitative lesion volumetry in multiple sclerosis , 1998, Annals of neurology.
[10] W. Grodd,et al. In vivo assessment of N-acetylaspartate in brain in spongy degeneration (Canavan's disease) by proton spectroscopy , 1990, The Lancet.
[11] Jimmy D Bell,et al. 1H NMR study of cerebral development in the rat , 1989, NMR in biomedicine.
[12] D'Adamo Af,et al. Acetyl transport mechanisms. Involvement of N-acetyl aspartic acid in de novo fatty acid biosynthesis in the developing rat brain. , 1968 .
[13] B. Trapp,et al. Demyelination in the central nervous system mediated by an anti‐oligodendrocyte antibody , 1998, Journal of neuroscience research.
[14] P. Rakić. Limits of neurogenesis in primates. , 1985, Science.
[15] J. Coyle,et al. N‐Acetyl‐Aspartyl‐Glutamate: Regional Levels in Rat Brain and the Effects of Brain Lesions as Determined by a New HPLC Method , 1984, Journal of neurochemistry.
[16] M. Raff,et al. Effects of Thyroid Hormone on Embryonic Oligodendrocyte Precursor Cell Developmentin Vivoandin Vitro , 1997, Molecular and Cellular Neuroscience.
[17] P. Matthews,et al. Reversible decreases in N‐acetylaspartate after acute brain injury , 1995, Magnetic resonance in medicine.
[18] G J Barker,et al. Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions. , 1994, Brain : a journal of neurology.
[19] P M Matthews,et al. Imaging axonal damage of normal-appearing white matter in multiple sclerosis. , 1998, Brain : a journal of neurology.
[20] M. Noble,et al. Development of oligodendrocytes and Schwann cells studied with a monoclonal antibody against galactocerebroside. , 1982, Proceedings of the National Academy of Sciences of the United States of America.
[21] M. Noble,et al. Ciliary neurotrophic factor and leukemia inhibitory factor promote the generation, maturation and survival of oligodendrocytes in vitro. , 1994, Development.
[22] P. Reier,et al. Proteins of rat brain myelin in neonatal hypothyroidism , 1975, Brain Research.
[23] P M Matthews,et al. Assessment of lesion pathology in multiple sclerosis using quantitative MRI morphometry and magnetic resonance spectroscopy. , 1996, Brain : a journal of neurology.
[24] H. Tallan. Studies on the distribution of N-acetyl-L-aspartic acid in brain. , 1957, The Journal of biological chemistry.
[25] G. Almazan,et al. Triiodothyronine Stimulation of Oligodendroglial Differentiation and Myelination , 1985 .
[26] S. Takashima,et al. Neuronal maturation and N-acetyl-l-aspartic acid development in human fetal and child brains , 1997, Brain and Development.
[27] T. Nakada,et al. In vivo 1H and 31P NMR spectroscopy of the developing rat brain , 1992, Magnetic resonance in medicine.
[28] H. Tallan,et al. N-Acetyl-L-aspartic acid in brain. , 1956, The Journal of biological chemistry.
[29] T. Richards. Proton MR spectroscopy in multiple sclerosis: value in establishing diagnosis, monitoring progression, and evaluating therapy. , 1991, AJR. American journal of roentgenology.
[30] William H. Oldendorf,et al. N-Acetyl-L-Aspartic acid: A literature review of a compound prominent in 1H-NMR spectroscopic studies of brain , 1989, Neuroscience & Biobehavioral Reviews.
[31] Y. Anikster,et al. The molecular basis of canavan (aspartoacylase deficiency) disease in European non-Jewish patients. , 1995, American journal of human genetics.
[32] C. Lucchinetti,et al. Multiple sclerosis: lessons from neuropathology. , 1998, Seminars in neurology.
[33] A. Ishikawa,et al. [Effects of neonatal hypothyroidism on brain development: analysis of brain metabolites using high resolution phosphorus and proton magnetic resonance (NMR) spectroscopy]. , 1990, No to hattatsu = Brain and development.
[34] D. Gadian,et al. Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[35] M. Raff,et al. Cell-intrinsic timers and thyroid hormone regulate the probability of cell-cycle withdrawal and differentiation of oligodendrocyte precursor cells. , 1998, Developmental biology.
[36] P. Timiras,et al. Influence of thyroid hormones on myelin proteins in the developing rat brain , 1975, Journal of the Neurological Sciences.
[37] Postnatal neurogenesis in the caudate nucleus and nucleus accumbens septi in the rat. , 1970, Brain research.
[38] N. Rosman,et al. Myelination of brain in experimental hypothyroidism An electron-microscopic and biochemical study of purified myelin isolates , 1975, Journal of the Neurological Sciences.
[39] G H Sato,et al. Growth of a rat neuroblastoma cell line in serum-free supplemented medium. , 1979, Proceedings of the National Academy of Sciences of the United States of America.
[40] M. Raff,et al. Rat neural antigen-2 (RAN-2): A cell surface antigen on astrocytes, ependymal cells, Müller cells and lepto-meninges defined by a monoclonal antibody , 1981, Brain Research.
[41] M. Noble,et al. Evidence for the existence of at least two timing mechanisms that contribute to oligodendrocyte generation in vitro. , 1996, Developmental biology.
[42] T. Patel,et al. Synthesis of N-acetyl-L-aspartate by rat brain mitochondria and its involvement in mitochondrial/cytosolic carbon transport. , 1979, The Biochemical journal.
[43] P M Matthews,et al. Axonal dysfunction and disability in a relapse of multiple sclerosis: Longitudinal study of a patient , 1997, Neurology.
[44] J. Coyle,et al. Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies , 1991, Neuroscience.
[45] Peter M. G. Munro,et al. Inhibition of N-acetylaspartate production: implications for 1H MRS studies in vivo. , 1996, Neuroreport.
[46] O. H. Lowry,et al. Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.
[47] O. Pryds,et al. Metabolite concentrations in the developing brain estimated with proton MR spectroscopy , 1994, Journal of magnetic resonance imaging : JMRI.
[48] B. Barres,et al. Multiple extracellular signals are required for long-term oligodendrocyte survival. , 1993, Development.
[49] J. Neale,et al. Immunohistochemical localization of N-acetylaspartate in rat brain. , 1991, Neuroreport.
[50] E J Holborow,et al. Fading of immunofluorescence during microscopy: a study of the phenomenon and its remedy. , 1982, Journal of immunological methods.
[51] M. Nirenberg,et al. Monoclonal antibody to a plasma membrane antigen of neurons. , 1979, Proceedings of the National Academy of Sciences of the United States of America.
[52] H. Thoenen,et al. Ciliary Neurotrophic Factor Enhances the Rate of Oligodendrocyte Generation , 1996, Molecular and Cellular Neuroscience.
[53] J. Cooper,et al. N‐ACETYL‐l‐ASPARTIC ACID CONTENT OF HUMAN NEURAL TUMOURS AND BOVINE PERIPHERAL NERVOUS TISSUES , 1972, Journal of neurochemistry.
[54] S. Bayer,et al. Development of the lateral and medial limbic cortices in the rat in relation to cortical phylogeny , 1990, Experimental Neurology.
[55] O. Bogler,et al. Cooperation between two growth factors promotes extended self-renewal and inhibits differentiation of oligodendrocyte-type-2 astrocyte (O-2A) progenitor cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[56] T. Noguchi,et al. Partial Restoration of Cerebral Myelination of the Congenitally Hypothyroid Mouse by Parenteral or Breast Milk Administration of Thyroxine , 1985, Journal of neurochemistry.
[57] W. Richardson,et al. Cell death and control of cell survival in the oligodendrocyte lineage , 1992, Cell.
[58] R. McKinnon,et al. Regulation of Oligodendrocyte Development and CNS Myelination by Growth Factors: Prospects for Therapy of Demyelinating Disease , 1996, Brain pathology.
[59] S. P. Porterfield,et al. The role of thyroid hormones in prenatal and neonatal neurological development--current perspectives. , 1993, Endocrine reviews.
[60] R. McKay,et al. Discussion point stem cells and neurogenesis in the adult brain , 1998, Current Opinion in Neurobiology.
[61] H. Thoenen,et al. Regional distribution, developmental changes, and cellular localization of CNTF-mRNA and protein in the rat brain , 1991, The Journal of cell biology.